GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease

D Wang, EA Day, LK Townsend, D Djordjevic… - Nature Reviews …, 2021 - nature.com
Abstract Growth differentiation factor 15 (GDF15) is a member of the TGFβ superfamily
whose expression is increased in response to cellular stress and disease as well as by …

[HTML][HTML] Towards frailty biomarkers: Candidates from genes and pathways regulated in aging and age-related diseases

AL Cardoso, A Fernandes, JA Aguilar-Pimentel… - Ageing research …, 2018 - Elsevier
Objective Use of the frailty index to measure an accumulation of deficits has been proven a
valuable method for identifying elderly people at risk for increased vulnerability, disease …

The GDF15-GFRAL pathway in health and metabolic disease: friend or foe?

SN Breit, DA Brown, VWW Tsai - Annual review of physiology, 2021 - annualreviews.org
GDF15 is a cell activation and stress response cytokine of the glial cell line–derived
neurotrophic factor family within the TGF-β superfamily. It acts through a recently identified …

[HTML][HTML] Metformin triggers a kidney GDF15-dependent area postrema axis to regulate food intake and body weight

SY Zhang, K Bruce, Z Danaei, RJW Li, DR Barros… - Cell Metabolism, 2023 - cell.com
Metformin, the most widely prescribed medication for obesity-associated type 2 diabetes
(T2D), lowers plasma glucose levels, food intake, and body weight in rodents and humans …

Identification of biomarkers for glycaemic deterioration in type 2 diabetes

RC Slieker, LA Donnelly, E Akalestou… - Nature …, 2023 - nature.com
We identify biomarkers for disease progression in three type 2 diabetes cohorts
encompassing 2,973 individuals across three molecular classes, metabolites, lipids and …

Metformin and growth differentiation factor 15 (GDF15) in type 2 diabetes mellitus: A hidden treasure

HM Al‐kuraishy, AI Al‐Gareeb, A Alexiou… - Journal of …, 2022 - Wiley Online Library
Type 2 diabetes mellitus (T2DM) is a chronic endocrine disorder due to the reduction of
insulin sensitivity and relative deficiency of insulin secretion. Growth differentiation factor 15 …

The anti-diabetic effects of NAG-1/GDF15 on HFD/STZ-induced mice

P Lertpatipanpong, J Lee, I Kim, T Eling, SY Oh… - Scientific reports, 2021 - nature.com
Nonsteroidal anti-inflammatory drug-activated gene-1 (NAG-1) plays a role in various
diseases. Here, the anti-diabetic effects of NAG-1 were evaluated using a high-fat …

GDF15 deficiency exacerbates chronic alcohol-and carbon tetrachloride-induced liver injury

HK Chung, JT Kim, HW Kim, M Kwon, SY Kim… - Scientific reports, 2017 - nature.com
Abstract Growth differentiation factor 15 (GDF15) has recently been shown to have an
important role in the regulation of mitochondrial function and in the pathogenesis of complex …

Growth differentiation factor 15: A novel biomarker with high clinical potential

S Desmedt, V Desmedt, L De Vos… - Critical Reviews in …, 2019 - Taylor & Francis
Initially considered as a macrophage inhibitor (macrophage inhibitory cytokine-1), growth
differentiation factor 15 (GDF-15) has been identified as a pleiotropic protein that plays key …

The mitochondrial unfolded protein response and mitohormesis: a perspective on metabolic diseases

HS Yi, JY Chang, M Shong - Journal of molecular …, 2018 - jme.bioscientifica.com
Mitochondria perform essential roles as crucial organelles for cellular and systemic energy
homeostasis, and as signaling hubs, which coordinate nuclear transcriptional responses to …